Jade Biosciences, Inc. (JBIO)

Jade Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	107.25	88.44	69.39	23.49	22.4	54.2
Short-Term Investments	353.96	247.72	-	98.95	106.82	113.18
Cash & Short-Term Investments	461.21	336.16	69.39	122.44	129.22	167.38
Cash Growth	108.75%	384.47%	-43.33%	-5.25%	-22.80%	3560.07%
Other Current Assets	10.05	12.66	0.27	1.79	2.28	6.96
Total Current Assets	471.25	348.82	69.65	124.23	131.5	174.33
Net Property, Plant & Equipment	0.79	0.9	-	0.9	1.25	0.73
Other Long-Term Assets	0.07	0.07	3.15	2.28	2.56	0.3
Total Assets	472.11	349.78	72.8	127.42	135.3	175.36

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.58	2.15	1.29	2.4	2.58	1.21
Accrued Expenses	15.22	14.39	9.63	14.82	4.82	1.15
Current Portion of Leases	-	-	-	0.42	0.39	0.19
Other Current Liabilities	9.77	-	1.08	-	-	-
Total Current Liabilities	31.57	16.54	12	17.64	7.78	2.55
Long-Term Debt	-	-	107.6	-	-	-
Long-Term Leases	0.63	0.72	-	0.26	0.71	0.38
Other Long-Term Liabilities	-	-	-	0.07	0.07	0.01
Total Long-Term Liabilities	0.63	0.72	107.6	0.33	0.78	0.4
Total Liabilities	32.2	17.26	119.6	17.96	8.56	2.95

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Preferred Stock	0	0	-	-	-	-
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	711.09	506.77	0.18	272.64	215.11	208.87
Accumulated Other Comprehensive Income	-0.66	0.13	-	0.24	-0.47	-0.06
Retained Earnings	-270.52	-174.39	-46.98	-163.42	-87.9	-36.39
Total Common Shareholders' Equity	439.92	332.52	-46.8	109.46	126.74	172.42
Minority Interest	-	-	0	-	-	-
Shareholders' Equity	439.92	332.52	-46.8	109.46	126.74	172.42
Total Liabilities & Equity	472.11	349.78	72.8	127.42	135.3	175.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.63	0.72	107.6	0.68	1.09	0.57
Net Cash (Debt)	460.58	335.43	-38.21	121.76	128.13	166.8
Net Cash Growth	109.21%	-	-	-4.97%	-23.18%	3547.52%
Net Cash Per Share	8.67	10.70	-46.80	161.85	183.25	474.88
Book Value	439.92	332.52	-46.8	109.46	126.74	172.42
Book Value Per Share	8.28	10.60	-57.31	145.49	181.27	490.88
Tangible Book Value	439.92	332.52	-46.8	109.46	126.74	172.42
Tangible Book Value Per Share	8.28	10.60	-57.31	145.49	181.27	490.88

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 10, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error